Skip to main content
. 2024 Jul 23;14:16895. doi: 10.1038/s41598-024-66473-4

Figure 8.

Figure 8

Cardiac glycoside drugs rescue CFTR from loss in differentiated BCi.NS1.1 (d-BCi) epithelia following infection by authentic SARS-CoV-2 virus. (a) Representative Western blot of protein samples collected from differentiated dBCi cells, cultured at the ALI for 28 days, and infected with SARS-CoV-2 (strain β 1.315). Conditions included medium only, virus only, and virus with 50 nM of either digitoxin or ouabain. Heating and disulfide bond breakage are omitted from the protein preparation, leaving the high molecular weight CFTR dimer to be detected. β-actin is used as a loading control. (b) Densitometry analysis was used to determine CFTR/β-actin ratio. Averages ± SD were calculated from N = 4 independent experiments. P values were determined with a one-way ANOVA, followed by a Dunnett’s post-hoc test comparing each mean to the medium control. A significant difference from the medium control was determined only for treatment with spike protein alone (p = 0.0103).